Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Oct 25, 2022

Total Value ($000): $240,208 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 33.4%

Value ($000) $80,252 Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 22.9%

Value ($000) $55,083 Shares 3,039,892 Est. Cost $17.87 Unrealized -15.3%

PCVX VAXCYTE INC 18.9%

Value ($000) $45,299 Shares 1,887,478 Est. Cost $32.16 Unrealized -21.2%

— MERUS N V 13.3%

Value ($000) $32,048 Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 11.5%

Value ($000) $27,526 Shares 2,484,274 Est. Cost $22.63 Unrealized -57.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$80,252	33.4%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$55,083	22.9%	$17.87	-15.3%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$45,299	18.9%	$32.16	-21.2%	COM	92243G108
—	MERUS N V	1,600,000	$32,048	13.3%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,484,274	$27,526	11.5%	$22.63	-57.9%	COM	71722W107